| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 133, Issue 2 754-757, Copyright © 1984 by American Association of Immunologists
ARTICLES |
S Jacobson, JR Richert, WE Biddison, A Satinsky, RJ Hartzman and HF McFarland
We have generated measles virus-specific T cell clones from a patient with multiple sclerosis who has been described previously as a strong responder to measles virus. T cell clones were screened on the basis of their capacity to proliferate to measles virus. The cell surface phenotype of each clone was OKT3+, OKT4+, OKT8-. The majority of these clones (11 of 14) were cytotoxic for their autologous measles virus- infected lymphoblastoid B cell target. This cytotoxicity was specific for measles virus inasmuch as these T cell clones could not lyse influenza or mumps virus-infected B cell targets. By using a panel of HLA-defined measles virus-infected B cell lines, these clones were shown to recognize measles virus in the context of HLA class II determinants. A monoclonal antibody that recognizes HLA class II monomorphic determinants (L243), but not a monoclonal antibody that recognizes HLA class I antigens (W6/32), inhibited the lysis of the autologous measles virus-infected B cell target by these T cell clones. These results demonstrate that these cytotoxic T cell clones specific for measles virus are HLA class II restricted.
This article has been cited by other articles:
|
|
 |
|
  N. R. Hegde, C. Dunn, D. M. Lewinsohn, M. A. Jarvis, J. A. Nelson, and D. C. Johnson Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL J. Exp. Med., October 17, 2005; 202(8): 1109 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Pan, A. Valsamakis, T. Colella, N. Nair, R. J. Adams, F. P. Polack, C. E. Greer, S. Perri, J. M. Polo, and D. E. Griffin Inaugural Article: Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles PNAS, August 16, 2005; 102(33): 11581 - 11588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Wilkinson, M. Simsova, E. Scholvinck, P. Sebo, C. Leclerc, H. M. Vordermeier, S. J. Dickson, J. R. Brown, R. N. Davidson, G. Pasvol, et al. Efficient Ex Vivo Stimulation of Mycobacterium tuberculosis-Specific T Cells by Genetically Detoxified Bordetella pertussis Adenylate Cyclase Antigen Toxoids Infect. Immun., May 1, 2005; 73(5): 2991 - 2998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Jellison, S.-K. Kim, and R. M. Welsh Cutting Edge: MHC Class II-Restricted Killing In Vivo during Viral Infection J. Immunol., January 15, 2005; 174(2): 614 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sugahara, S. Tsuji-Kawahara, and M. Miyazawa Identification of a Protective CD4+ T-Cell Epitope in p15gag of Friend Murine Leukemia Virus and Role of the MA Protein Targeting the Plasma Membrane in Immunogenicity J. Virol., June 15, 2004; 78(12): 6322 - 6334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yilla, C. Hickman, M. McGrew, E. Meade, and W. J. Bellini Edmonston Measles Virus Prevents Increased Cell Surface Expression of Peptide-Loaded Major Histocompatibility Complex Class II Proteins in Human Peripheral Monocytes J. Virol., September 1, 2003; 77(17): 9412 - 9421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Yanai, E. Ishii, K. Kojima, A. Hasegawa, T. Azuma, S. Hirose, N. Suga, A. Mitsudome, M. Zaitsu, Y. Ishida, et al. Essential Roles of Perforin in Antigen-Specific Cytotoxicity Mediated by Human CD4+ T Lymphocytes: Analysis Using the Combination of Hereditary Perforin-Deficient Effector Cells and Fas-Deficient Target Cells J. Immunol., February 15, 2003; 170(4): 2205 - 2213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. VanLith, K. G. Kohlgraf, C. L. Sivinski, R. M. Tempero, and M. A. Hollingsworth MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responses Int. Immunol., August 1, 2002; 14(8): 873 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Cao, P. Meuleman, I. Desombere, M. Sallberg, and G. Leroux-Roels In Vivo Inhibition of Anti-Hepatitis B Virus Core Antigen (HBcAg) Immunoglobulin G Production by HBcAg-Specific CD4+ Th1-Type T-Cell Clones in a hu-PBL-NOD/SCID Mouse Model J. Virol., December 1, 2001; 75(23): 11449 - 11456. [Abstract] [Full Text]
|
|
|
|
|
|
P. J. Norris, M. Sumaroka, C. Brander, H. F. Moffett, S. L. Boswell, T. Nguyen, Y. Sykulev, B. D. Walker, and E. S. Rosenberg Multiple Effector Functions Mediated by Human Immunodeficiency Virus-Specific CD4+ T-Cell Clones J. Virol., October 15, 2001; 75(20): 9771 - 9779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Woelk, L. Jin, E. C. Holmes, and D. W. G. Brown Immune and artificial selection in the haemagglutinin (H) glycoprotein of measles virus J. Gen. Virol., October 1, 2001; 82(10): 2463 - 2474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nanan, A. Rauch, E. Kämpgen, S. Niewiesk, and H. W. Kreth A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles J. Gen. Virol., May 1, 2000; 81(5): 1313 - 1319. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Pinilla-Ibarz, K. Cathcart, T. Korontsvit, S. Soignet, M. Bocchia, J. Caggiano, L. Lai, J. Jimenez, J. Kolitz, and D. A. Scheinberg Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses Blood, March 1, 2000; 95(5): 1781 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Schmidt Candidate autoantigens in multiple sclerosis Multiple Sclerosis, June 1, 1999; 5(3): 147 - 160. [Abstract] [PDF]
|
|
|
|
|
|
S. J. Gagnon, F. A. Ennis, and A. L. Rothman Bystander Target Cell Lysis and Cytokine Production by Dengue Virus-Specific Human CD4+ Cytotoxic T-Lymphocyte Clones J. Virol., May 1, 1999; 73(5): 3623 - 3629. [Abstract] [Full Text]
|
|
|
|
|
|
H. Ohminami, M. Yasukawa, S. Kaneko, Y. Yakushijin, Y. Abe, Y. Kasahara, Y. Ishida, and S. Fujita Fas-Independent and Nonapoptotic Cytotoxicity Mediated by a Human CD4+ T-Cell Clone Directed Against an Acute Myelogenous Leukemia-Associated DEK-CAN Fusion Peptide Blood, February 1, 1999; 93(3): 925 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Fujinami, X. Sun, J. M. Howell, J. C. Jenkin, and J. B. Burns Modulation of Immune System Function by Measles Virus Infection: Role of Soluble Factor and Direct Infection J. Virol., December 1, 1998; 72(12): 9421 - 9427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yasukawa, H. Ohminami, S. Kaneko, Y. Yakushijin, Y. Nishimura, K. Inokuchi, T. Miyakuni, S. Nakao, K. Kishi, I. Kubonishi, et al. CD4+ Cytotoxic T-Cell Clones Specific for bcr-abl b3a2 Fusion Peptide Augment Colony Formation by Chronic Myelogenous Leukemia Cells in a b3a2-Specific and HLA-DR-Restricted Manner Blood, November 1, 1998; 92(9): 3355 - 3361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chen, M. Shirai, Z. Liu, T. Arichi, H. Takahashi, and M. Nishioka Efficient Class II Major Histocompatibility Complex Presentation of Endogenously Synthesized Hepatitis C Virus Core Protein by Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Lines to CD4+ T Cells J. Virol., October 1, 1998; 72(10): 8301 - 8308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Suzumura, E Lavi, Weiss SR, and D. Silberberg Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes Science, May 23, 1986; 232(4753): 991 - 993. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
